RecruitingPhase 1NCT06995729
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Studying Holt-Oram syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pfizer
- Principal Investigator
- Pfizer CT.gov Call CenterPfizer
- Intervention
- Zavegepant(drug)
- Enrollment
- 16 target
- Eligibility
- 6-11 years · All sexes
- Timeline
- 2025 – 2027
Study locations (13)
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- Velocity Clinical Research, Washington DC, Washington D.C., District of Columbia, United States
- Coastal Heritage Clinical Research, Hinesville, Georgia, United States
- Clinical Research Institute, Minneapolis, Minnesota, United States
- Children's Hospital & Medical Center, Omaha, Nebraska, United States
- True North Neurology, Port Jefferson Station, New York, United States
- Accellacare - Piedmont, Statesville, North Carolina, United States
- Accellacare of Piedmont HealthCare, Statesville, North Carolina, United States
- Accellacare US Inc., Winston-Salem, North Carolina, United States
- Central States Research, Tulsa, Oklahoma, United States
- Cedar Health Research, Dallas, Texas, United States
- Wasatch Clinical Research, LLC, Salt Lake City, Utah, United States
- Granger Medical Holladay - Holladay Clinic, Salt Lake City, Utah, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06995729 on ClinicalTrials.govOther trials for Holt-Oram syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT03895645Connors Protocol for the Management and Use of Stored Human Specimens (Stored Human Specimens)National Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNANCT07352683Open TAP-block in Pediatric Abdominal SurgeryUppsala University
- RECRUITINGNANCT07301489Akershus Cardiac Examination (ACE) 5 StudyUniversity Hospital, Akershus
- RECRUITINGPHASE3NCT07000357A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First EventAstraZeneca
- RECRUITINGNCT06761105Using Anonymous Data From A Digital Tool for Medical History-Taking To Improve Healthcare ServicesUniversity Hospital Goettingen
- ACTIVE NOT RECRUITINGPHASE2NCT06897748A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated EosinophilsAstraZeneca
- ACTIVE NOT RECRUITINGNCT06735742A Study to Learn About the Safety of TALZENNA for the Treatment of Breast CancerPfizer
- RECRUITINGNANCT06814977An Acupuncture Study for Cancer Survivors With Joint PainMemorial Sloan Kettering Cancer Center